Business · 24/10/2023Updated: 10/17/2026 · 1 min read
FDA Releases Revised Draft Guidance on Communications with Healthcare Providers about Unapproved Medical Product Uses
Summary
The Food and Drug Administration (FDA) has released a revised draft guidance to address common questions about communications between pharmaceutical companies and healthcare providers regarding unapproved uses of approved medical products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →